Clinical and MRI effects", "sentences": [], "annotations": [], "relations": []}, {"offset": 39156, "infons": {"fpage": "1203", "lpage": "11", "name_0": "surname:Osborn;given-names:L", "name_1": "surname:Hession;given-names:C", "name_2": "surname:Tizard;given-names:R", "pub-id_pmid": "2688898", "section_type": "REF", "source": "Cell", "type": "ref", "volume": "59", "year": "1989"}, "text": "Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes", "sentences": [], "annotations": [], "relations": []}, {"offset": 39285, "infons": {"fpage": "899", "lpage": "910", "name_0": "surname:Polman;given-names:CH", "name_1": "surname:O'Connor;given-names:PW", "name_2": "surname:Havrdova;given-names:E", "pub-id_pmid": "16510744", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "354", "year": "2006"}, "text": "A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39372, "infons": {"fpage": "1498", "lpage": "504", "pub-id_pmid": "9820297", "section_type": "REF", "source": "Lancet", "type": "ref", "volume": "352", "year": "1998"}, "text": "Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39485, "infons": {"fpage": "1628", "lpage": "36", "pub-id_pmid": "11425926", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "56", "year": "2001"}, "text": "PRISMS-4: long-term efficacy of interferon-beta-1a in relapsing MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 39552, "infons": {"comment": "CD002002", "name_0": "surname:Rice;given-names:G PA", "name_1": "surname:Incorvaia;given-names:B", "name_2": "surname:Munari;given-names:L", "section_type": "REF", "source": "Cochrane Database Syst Rev", "type": "ref", "volume": "4", "year": "2001"}, "text": "Interferon in relapsing-remitting multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39605, "infons": {"fpage": "A381", "issue": "suppl 2", "lpage": "2", "name_0": "surname:Rudick;given-names:RA", "name_1": "surname:Hutchinson;given-names:M", "name_2": "surname:O'Connor;given-names:P", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "66", "year": "2006"}, "text": "Natalizumab improves health-related quality of life in patients with relapsing multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39703, "infons": {"fpage": "571", "lpage": "80", "name_0": "surname:Rudick;given-names:RA", "name_1": "surname:Sandrock;given-names:A", "section_type": "REF", "source": "Expert Rev Neurotherapeutics", "type": "ref", "volume": "4", "year": "2004"}, "text": "Natalizumab: alpha4-integrin antagonist selective adhesion molecule inhibitors for MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 39789, "infons": {"fpage": "911", "lpage": "23", "name_0": "surname:Rudick;given-names:RA", "name_1": "surname:Stuart;given-names:WH", "name_2": "surname:Calabresi;given-names:PA", "pub-id_pmid": "16510745", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "354", "year": "2006"}, "text": "A randomized, placebo-controlled trial of natalizumab plus interferon beta-1a for relapsing multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39900, "infons": {"fpage": "1072", "lpage": "4", "name_0": "surname:Sheremata;given-names:WA", "name_1": "surname:Vollmer;given-names:TL", "name_2": "surname:Stone;given-names:LA", "pub-id_pmid": "10102433", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "52", "year": "1999"}, "text": "A safety and pharmacokinetic study of intravenous natalizumab in patients with MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 39982, "infons": {"fpage": "466", "lpage": "72", "name_0": "surname:Tubridy;given-names:N", "name_1": "surname:Behan;given-names:PO", "name_2": "surname:Capildeo;given-names:R", "pub-id_pmid": "10449105", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "53", "year": "1999"}, "text": "The effect of anti-alpha4 integrin antibody on brain lesion activity in MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 40057, "infons": {"section_type": "REF", "source": "Tysabri  (natalizumab) package insert", "type": "ref", "year": "2006"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 40058, "infons": {"fpage": "362", "lpage": "8", "name_0": "surname:Van Assche;given-names:G", "name_1": "surname:Van Ranst;given-names:M", "name_2": "surname:Sciot;given-names:R", "pub-id_pmid": "15947080", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volu